Two Sigma Advisers’s AMN Healthcare AMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-503,900
| Closed | -$7.94M | – | 111 |
|
|
2025
Q4 | $7.94M | Buy |
503,900
+131,700
| +35% | +$2.35M | 0.02% | 621 |
|
|
2025
Q3 | $7.21M | Buy |
372,200
+133,200
| +56% | +$2.6M | 0.01% | 609 |
|
|
2025
Q2 | $4.94M | Buy |
239,000
+22,200
| +10% | +$462K | 0.01% | 747 |
|
|
2025
Q1 | $5.3M | Buy |
216,800
+5,000
| +2% | +$128K | 0.01% | 766 |
|
|
2024
Q4 | $5.07M | Buy |
211,800
+178,400
| +534% | +$5.67M | 0.01% | 717 |
|
|
2024
Q3 | $1.42M | Buy |
+33,400
| New | +$1.75M | ﹤0.01% | 1252 |
|
|
2022
Q3 | – | Sell |
-4,100
| Closed | -$450K | – | 2534 |
|
|
2022
Q2 | $450K | Sell |
4,100
-1,600
| -28% | -$158K | ﹤0.01% | 1964 |
|
|
2022
Q1 | $595K | Sell |
5,700
-10,600
| -65% | -$1.1M | ﹤0.01% | 1900 |
|
|
2021
Q4 | $1.99M | Sell |
16,300
-100
| -0.6% | -$11.1K | 0.01% | 1199 |
|
|
2021
Q3 | $1.88M | Buy |
+16,400
| New | +$1.74M | ﹤0.01% | 1292 |
|
|
2020
Q4 | – | Sell |
-6,200
| Closed | -$362K | – | 2373 |
|
|
2020
Q3 | $362K | Buy |
+6,200
| New | +$326K | ﹤0.01% | 1947 |
|
|
2017
Q2 | – | Sell |
-13,669
| Closed | -$555K | – | 2250 |
|
|
2017
Q1 | $555K | Sell |
13,669
-77,700
| -85% | -$3.04M | ﹤0.01% | 1848 |
|
|
2016
Q4 | $3.51M | Sell |
91,369
-64,200
| -41% | -$2.19M | 0.01% | 901 |
|
|
2016
Q3 | $4.96M | Buy |
155,569
+44,000
| +39% | +$1.67M | 0.02% | 649 |
|
|
2016
Q2 | $4.46M | Sell |
111,569
-119,000
| -52% | -$4.4M | 0.02% | 589 |
|
|
2016
Q1 | $7.75M | Sell |
230,569
-127,110
| -36% | -$3.63M | 0.04% | 393 |
|
|
2015
Q4 | $11.1M | Sell |
357,679
-93,599
| -21% | -$2.77M | 0.07% | 301 |
|
|
2015
Q3 | $13.8M | Buy |
451,278
+217,308
| +93% | +$7.17M | 0.09% | 269 |
|
|
2015
Q2 | $7.39M | Buy |
233,970
+75,701
| +48% | +$1.98M | 0.06% | 376 |
|
|
2015
Q1 | $3.65M | Buy |
158,269
+99,000
| +167% | +$2.05M | 0.03% | 569 |
|
|
2014
Q4 | $1.16M | Sell |
59,269
-66,900
| -53% | -$1.15M | 0.01% | 1096 |
|
|
2014
Q3 | $1.98M | Sell |
126,169
-82,100
| -39% | -$1.17M | 0.01% | 812 |
|
|
2014
Q2 | $2.56M | Sell |
208,269
-8,400
| -4% | -$100K | 0.02% | 708 |
|
|
2014
Q1 | $2.98M | Buy |
216,669
+21,400
| +11% | +$308K | 0.03% | 604 |
|
|
2013
Q4 | $2.87M | Buy |
195,269
+173,900
| +814% | +$2.35M | 0.03% | 578 |
|
|
2013
Q3 | $294K | Sell |
21,369
-5,800
| -21% | -$85.2K | ﹤0.01% | 1712 |
|
|
2013
Q2 | $389K | Buy |
+27,169
| New | +$382K | 0.01% | 1520 |
|
Other funds holding AMN
VCM
VPM
Two Sigma Advisers's AMN Position: Q1 2026 in Review
Two Sigma Advisers sold out of AMN Healthcare (AMN) in Q1 2026, closing a stake of 503,900 shares — an estimated $7.94M sold.
Two Sigma Advisers first reported a position in AMN in Q2 2013 and held it in 27 quarters. The position peaked at $13.8M in Q3 2015. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.
- Two Sigma Advisers reported no remaining AMN Healthcare position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 503,900 AMN Healthcare shares in Q1 2026, an estimated $7.94M.
- Two Sigma Advisers first reported a position in AMN Healthcare in Q2 2013 and held it in 27 quarters.
- Two Sigma Advisers's AMN Healthcare position peaked at $13.8M in Q3 2015.
- 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.